| | | | |
CUSIP No. 023111206 | | | | Page 4 of 5 Pages |
| | SCHEDULE 13D | | |
This Amendment No. 3 to Schedule 13D (“Amendment No. 3”) relates to American Depositary Shares (“ADS(s)”), each ADS representing one ordinary share, par value 50 pence per share (the “Ordinary Shares”), issued by Amarin Corporation plc, a company incorporated under the laws of England and Wales (the “Issuer”), and amends the initial statement on Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on January 24, 2022 (the “Initial Schedule 13D”) as amended by Amendment No. 1 to Schedule 13D filed on June 3, 2022 and Amendment No. 2 to Schedule 13D filed on June 16, 2022 (the Initial Schedule 13D, as so amended, the “Schedule 13D”) on behalf of the Reporting Persons, to furnish the additional information set forth herein. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.
Item 4. Purpose of Transaction. Item 4 of the Schedule 13D is hereby amended to include the following:
On October 11, 2022, Sarissa Capital issued a press release indicating that the Reporting Persons have commenced the process to call a special meeting of shareholders to remove and replace certain of the Issuer’s directors. A copy of the press release is attached as Exhibit 3 hereto.
Item 5. Interest in Securities of the Issuer. Item 5(a) of the Schedule 13D is hereby amended and restated as follows:
The Reporting Persons may be deemed to beneficially own, in the aggregate, 24,000,000 Shares representing approximately 5.95% of the outstanding Shares, based upon the 403,205,514 Shares outstanding as of July 29, 2022, including 403,021,687 ADSs, and 183,827 Ordinary Shares, as set forth in the Form 10-Q of the Issuer filed with the SEC on August 3, 2022.
Item 7. Material to Be Filed as Exhibits. Item 7 of the Schedule 13D is hereby amended to include the following:
Exhibit 3 – Press Release, October 11, 2022